|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
07/28/2016 |
$0.22 |
$0.26 |
$0.15 |
$0.15 |
9.06M | 07/29/2016 |
$0.17 |
$0.17 |
$0.13 |
$0.14 |
4.00M | 08/01/2016 |
$0.14 |
$0.22 |
$0.14 |
$0.17 |
8.95M | 08/02/2016 |
$0.17 |
$0.18 |
$0.14 |
$0.15 |
4.09M | 08/03/2016 |
$0.15 |
$0.15 |
$0.14 |
$0.14 |
2.02M |
|
EPIRUS Biopharmaceuticals is a biopharmaceutical company engaged in developing, manufacturing, and commercializing biosimilar therapeutics (biosimilars). Co.'s primary product candidate is BOW015, a biosimilar version of Remicade®. Remicade is marketed by Johnson & Johnson, Merck Schering and Mitsubishi Tanabe for the treatment of various inflammatory diseases. Co.'s biosimilar product candidates also includes BOW050, a biosimilar version of Humira®, which is marketed by AbbVie and used to treat inflammatory diseases, and BOW070, a biosimilar version of Actemra®, which is marketed by Genentech/Roche and used to treat inflammatory diseases. BOW050 and BOW070 are in preclinical development. | |
|
EPRS (EPRS) has the following price history information. Looking back at EPRS historical stock prices for the last five trading days, on July 28, 2016, EPRS opened at $0.22, traded as high as $0.26 and as low as $0.15, and closed at $0.15. Trading volume was a total of 9.06M shares. On July 29, 2016, EPRS opened at $0.17, traded as high as $0.17 and as low as $0.13, and closed at $0.14. Trading volume was a total of 4.00M shares. On August 01, 2016, EPRS opened at $0.14, traded as high as $0.22 and as low as $0.14, and closed at $0.17. Trading volume was a total of 8.95M shares. On August 02, 2016, EPRS opened at $0.17, traded as high as $0.18 and as low as $0.14, and closed at $0.15. Trading volume was a total of 4.09M shares. On August 03, 2016, EPRS opened at $0.15, traded as high as $0.15 and as low as $0.14, and closed at $0.14. Trading volume was a total of 2.02M shares.
EPRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into EPRS shares, starting with a $10,000 purchase of EPRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
08/03/2016 |
|
Start price/share: |
$12.20 |
|
End price/share: |
$0.14 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.85% |
|
Average Annual Total Return: |
-85.12% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$114.71 |
|
Years: |
2.35 |
|
|
|
Date |
Close |
07/28/2016 | $0.15 | 07/29/2016 | $0.14 | 08/01/2016 | $0.17 | 08/02/2016 | $0.15 | 08/03/2016 | $0.14 |
|
|